CN109686416A - A kind of system and method for Rapid matching drug - Google Patents
A kind of system and method for Rapid matching drug Download PDFInfo
- Publication number
- CN109686416A CN109686416A CN201910005451.7A CN201910005451A CN109686416A CN 109686416 A CN109686416 A CN 109686416A CN 201910005451 A CN201910005451 A CN 201910005451A CN 109686416 A CN109686416 A CN 109686416A
- Authority
- CN
- China
- Prior art keywords
- drug
- information
- rapid matching
- identification
- mobile terminal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K7/00—Methods or arrangements for sensing record carriers, e.g. for reading patterns
- G06K7/10—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation
- G06K7/14—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation using light without selection of wavelength, e.g. sensing reflected white light
- G06K7/1404—Methods for optical code recognition
- G06K7/1408—Methods for optical code recognition the method being specifically adapted for the type of code
- G06K7/1417—2D bar codes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Electromagnetism (AREA)
- Toxicology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The system that the present invention discloses a kind of Rapid matching drug, including database and multiple mobile terminals, the database includes that drug illustrates information, pharmacogenomic information or the medication guide information based on genetic test result or personal feature, and the mobile terminal is equipped with the device of identification drug and the display device for showing medication guide information.The present invention utilizes the convenience of mobile terminal and the recognition capability to drug, rapidly by certain certain drug and illustrate that information, pharmacogenomic information and personalized medicine tutorial message based on user's genetic test result or personal feature match, to rapidly remind the risk of user people to be matched.
Description
Technical field
The invention belongs to gene fields, more particularly, to a kind of system and method for Rapid matching drug.
Background technique
28 Jin Saite June in 1997 (Paris) can Bert laboratory announce to set up in the world first unique gene with
Drugmaker, study different genes caused by differential responses of the various disease to drug, and develop on this basis new drug or
New administrated method, this new concept are referred to as pharmacogenomics.
Pharmacogenomics can be described as the combination of gene function Yu molecular pharmacology, in many this knots of aspect
Conjunction is very important.Pharmacogenomics are different from genetics in general sense, it is not to find human genome base
Cause as the main purpose, but relatively simply improves the treatment of patient with known gene theory.Also it may be said that drug
Genomics studies the relationship of various different genes and drug effect and safety using drug effect and safety as target.
Just because of pharmacogenomics are research gene order and its science to drug differential responses, so it is research
Efficiently, suitable drug is found by it for patient or specific crowd in the important channel of specific medicament, and pharmacogenomics are strong
Adjust individuation；It suits measures to different persons, there is important theory significance and wide application prospect.
Therefore, FDA has modified drug specification, and the influence to gene towards drug provides warning prompt, proposes (gene inspection
Survey) level of evidence: clinical efficacy, FDA or academic research or other professional teams, clinical medicine base was carried out to the drug
Because of a group analysis and assessment.It mainly include cardiovascular drugs, communicable disease drug, antineoplastic, aromatase inhibitor etc..
In July, 2015, national health State Family Planning Commission doctor political affairs doctor pipe office print and distribute " drug metabolic enzyme and the inspection of drug target point gene
Survey technology guide (tentative) ", main contents include drug metabolic enzyme and drug target GENE Assay analysis before, analysis neutralizes
Quality assurance specifications after analysis, it is intended to the matter of drug metabolic enzyme and drug target genetic test is carried out for Clinical Test Lab
Amount guarantees that providing overall process dynamic instructs, to realize personalized medicine, improves the validity and safety of drug therapy, prevents
The generation of severe drug adverse reaction.
And it can quickly know the user of drug if appropriate for the drug there is no a tool at present.
Summary of the invention
It is an object of the invention to help individual quickly to identify drug to be used if appropriate for using, to avoid because of individual
Side effect risk, drug effect reduction or invalid phenomenon caused by gene is different.
According to object above, system that the present invention provides a kind of Rapid matching drug first, which is characterized in that including data
Library and mobile terminal, the database include that general information, pharmacogenomic information, genetic test result information and individual are special
The medication guide information of sign, the mobile terminal is equipped with the device of identification drug and the display for showing medication guide information fills
It sets.Using the convenience of mobile terminal, drug is quickly identified, database is recycled to carry out the matching of gene expression characteristics and drug.
Preferably, the device of the identification drug is pattern recognition device, barcode scanning device or input device.It is preferred that
, the barcode scanning device includes two-dimensional code scanning device or bar code scanner.
Preferably, the preparation method of the gene expression characteristics is to directly input, scan the peculiar mark of gene expression characteristics or sweep
Retouch the two dimensional code of gene expression characteristics.
Preferably, the pattern recognition device includes identification drug outer packing, identification medicine bottle or identification nomenclature of drug
Device.
Preferably, the display device be also used to show identical function and the higher drug of matching degree.
A kind of method that the present invention further discloses Rapid matching drug, includes the following steps
S1. drug is identified using mobile terminal, and the information of drug is sent to database,
S2. database transfers the medication guide information based on genetic test result or personal feature to match with related drugs,
And the information is showed into user by mobile end equipment.
Preferably, the method for mobile terminal identification drug is image recognition, the identification of scanning drug two dimensional code, scanning medicine
Identification is manually entered in object bar code recognition.
It preferably, further include matching result being fed back to checking object or feeding back to doctor to checking object after S2
It is raw.
Preferably, further include recommend identical function and the higher drug of matching degree.
Compared with prior art, the beneficial effects of the present invention are:
The present invention utilizes the convenience Direct Recognition drug of mobile terminal, then according to existing disclosed based on genetic test result
Or the medication guide information of personal feature, will quickly prompt be used to feed back to user, to substantially reduce Yin Jiyin and lead
A possibility that drug ineffective of cause；Convenience using mobile terminal and the recognition capability to drug, quickly by drug and base
Because feature is matched, to effectively remind the relevant risk of user, and most suitable drug is recommended into user；Solution
Jue Liao unprofessional user obtains the drug gene characteristic information of individuation and the problem that related guidance proposed steps are many and diverse.
Specific embodiment
Following embodiment is described in detail a specific embodiment of the invention.
Embodiment 1
When there is one the people of lipid-lowering medicine is needed to need drug, then the genetic test information of first typing oneself passes through mobile phone
The two dimensional code (Lipitor) of atorvastatin is scanned, the information of atorvastatin is sent to database by mobile terminal,
Database transfers the drug information of atorvastatin, this drug information includes that (Pfizer has for the company-information of drug
Limit company), the main component (Atorvastatin) of drug, and matched with its gene expression characteristics, display result is good drug efficacy, secondary
Effect risk is normal, in addition can also show that the indication of drug is hypercholesterolemia and coronary heart disease, and provide data source
(source are as follows: official's drug specification).
Embodiment 2
When having another to be also required to the people of lipid-lowering medicine to need drug, then the genetic test information of first typing oneself is led to
The two dimensional code (Lipitor) of mobile phone scanning atorvastatin is crossed, the information of atorvastatin is sent to number by mobile terminal
According to library, database transfers the drug information of atorvastatin, this drug information includes company-information (Pfizer's system of drug
Medicine Co., Ltd), the main component (Atorvastatin) of drug, and matched with its gene expression characteristics, display result is drug effect
Difference, side effect risk is high, and provides under identical indication safer suitable drug candidate information as reference, such as general cuts down
Statin (Pa Wa stops).
Embodiment 3
Xiao Ming needs to lay in some common drugs at home, and all gene expression characteristics of the household of oneself are first passed through scanning two dimension by him
Code is scanned into his mobile terminal, is then scanned to the bar code of a variety of common medicines, or input drug name.
Fenbid is inputted, all matching results of its household are shown to mobile terminal by database, and display result is institute
Having per capita can normal use.
Aspirin is inputted, all matching results of its household are shown to mobile terminal by database, and display result mentions
Show father using aspirin drug effect it is poor/side effect risk is higher.
Combining preferred embodiment above, invention has been described, but the invention is not limited to implementations disclosed above
Example, and various modifications, equivalent combinations according to the essence of the present invention should be covered.
Claims (9)
1. a kind of system of Rapid matching drug, which is characterized in that including database and mobile terminal, the database includes medicine
Object general information, pharmacogenomic information or the medication guide information based on genetic test result or personal feature, it is described
Mobile terminal is equipped with the device of identification drug and the display device for showing medication guide information.
2. the system of Rapid matching drug according to claim 1, which is characterized in that the device of the identification drug is
Pattern recognition device, barcode scanning device or input device.
3. the system of Rapid matching drug according to claim 2, which is characterized in that the barcode scanning device is two dimensional code
Scanning means or bar code scanner.
4. the system of Rapid matching drug according to claim 1, which is characterized in that the pattern recognition device includes
Identify drug outer packing, identification medicine bottle or the device for identifying nomenclature of drug.
5. the system of Rapid matching drug according to claim 1, which is characterized in that the display device is also used to show
Show identical function and the higher drug of matching degree.
6. a kind of method of Rapid matching drug, which is characterized in that include the following steps
S1. drug is identified using mobile terminal, and the information of drug is sent to database,
S2. database transfers the medication guide information based on genetic test result or personal feature to match with related drugs,
And the information is showed into user by mobile end equipment.
7. the method for Rapid matching drug according to claim 6, which is characterized in that the mobile terminal identification drug
Method is image recognition, the identification of scanning drug two dimensional code, scanning drug bar code recognition or identification is manually entered.
8. the method for Rapid matching drug according to claim 6, which is characterized in that further include by matching result after S2
It feeds back to checking object or feeds back to doctor to checking object.
9. the method for Rapid matching drug according to claim 5, which is characterized in that further include recommend identical function and
The higher drug of matching degree.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910005451.7A CN109686416A (en) | 2019-01-03 | 2019-01-03 | A kind of system and method for Rapid matching drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910005451.7A CN109686416A (en) | 2019-01-03 | 2019-01-03 | A kind of system and method for Rapid matching drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109686416A true CN109686416A (en) | 2019-04-26 |
Family
ID=66191887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910005451.7A Pending CN109686416A (en) | 2019-01-03 | 2019-01-03 | A kind of system and method for Rapid matching drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109686416A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101029337A (en) * | 2006-03-01 | 2007-09-05 | 北京华安佛医药研究中心有限公司 | Use and method for predicting serotonin re-uptake inhibitor medicine effect by polymorphic site |
| US20100330063A1 (en) * | 2007-12-17 | 2010-12-30 | Gliamed, Inc. | Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells |
| CN102034016A (en) * | 2009-09-30 | 2011-04-27 | 帕斯维基因组学公司 | Genome-based medicament management system |
| CN102067142A (en) * | 2008-02-26 | 2011-05-18 | 普渡研究基金会 | Method for patient genotyping |
| CN107103199A (en) * | 2017-04-28 | 2017-08-29 | 为朔医学数据科技（北京）有限公司 | A kind of method and device of direction of medication usage |
| CN108682458A (en) * | 2018-05-08 | 2018-10-19 | 北京岙特杰诺生物科技有限公司 | Drug use administration method, apparatus and electronic equipment |
-
2019
- 2019-01-03 CN CN201910005451.7A patent/CN109686416A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101029337A (en) * | 2006-03-01 | 2007-09-05 | 北京华安佛医药研究中心有限公司 | Use and method for predicting serotonin re-uptake inhibitor medicine effect by polymorphic site |
| US20100330063A1 (en) * | 2007-12-17 | 2010-12-30 | Gliamed, Inc. | Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells |
| CN102067142A (en) * | 2008-02-26 | 2011-05-18 | 普渡研究基金会 | Method for patient genotyping |
| CN102034016A (en) * | 2009-09-30 | 2011-04-27 | 帕斯维基因组学公司 | Genome-based medicament management system |
| CN107103199A (en) * | 2017-04-28 | 2017-08-29 | 为朔医学数据科技（北京）有限公司 | A kind of method and device of direction of medication usage |
| CN108682458A (en) * | 2018-05-08 | 2018-10-19 | 北京岙特杰诺生物科技有限公司 | Drug use administration method, apparatus and electronic equipment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Evans et al. | Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis | |
| Newcombe | Confidence intervals for proportions and related measures of effect size | |
| Thomas et al. | Fake news: Medicines misinformation by the media. | |
| Chappuy et al. | Parental consent in paediatric clinical research | |
| CN109686416A (en) | A kind of system and method for Rapid matching drug | |
| Hicks | The randomised controlled trial: a critique | |
| Salunke et al. | Formulating better medicines for children—Still too far to walk | |
| Sharma et al. | Assessment of knowledge about pharmacovigilance among medical students in Puducherry | |
| Kristina | Profile and determinants of compounding services among pharmacists in Indonesia | |
| Roest et al. | Different methods of pain relief for IVF and ICSI oocyte retrieval–A Dutch survey | |
| Shah et al. | Recent advances in psychopharmacology: from bench to bedside novel trends in schizophrenia | |
| Chongpornchai et al. | Effectiveness of Motion Infographic Media on the Improvement of Knowledge and Medical Adherence in Human Immunodeficiency Virus Patients. | |
| Bajcetic et al. | Availability of oral formulations labeled for use in young children in Serbia, Germany and the USA | |
| Alshakka et al. | Pharmacovigilance: Our experience in Aden | |
| Lin et al. | Investigating the Possibility for is/IT to Support the Delivery of Chinese Medicine. | |
| Armstrong et al. | Emergency department presentations of naltrexone‐accelerated detoxification | |
| Najam et al. | Assessment of Prescription Errors among Community Pharmacists in Quetta Balochitsan, Pakistan | |
| Malik et al. | Stability of an extemporaneously compounded oral suspension of bosentan | |
| Chen et al. | Influence of Catheter–Incision Congruency in Epidural Analgesia on Postcesarean Pain Management: A Single-Blinded Randomized Controlled Trial | |
| Slater | The European Unions’ Clinical Trials Directive | |
| Pekari et al. | The Score Card Approach: A First Step Toward an Evidence-based Differentiation Assessment for Tablets | |
| Price et al. | Documenting and treating acute pain in children. | |
| Chaudhari et al. | Study of Rationality of Promotional Drug Literature Received At a Cancer Hospital | |
| Buisman | Different methods of pain relief for IVF and ICSI oocyte retrieval–a Dutch survey | |
| Ghasemi Charati et al. | Exploring the Experiences of the Teaching-Learning Process of Mazandaran University of Medical Sciences Officials During the Covid-19 Pandemic: Challenges and Strategies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190426 |